Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Limitations of Fixed Pricing Assumptions in Evaluating Cost-Effectiveness of Vasoplegia Protocols.

Journal of cardiothoracic and vascular anesthesia·2026
Same author

Point-of-Care Gastric Ultrasound-Guided Nasogastric Decompression in a Fasting Patient With Prior Aspiration: A Case Report.

A&A practice·2026
Same author

A Case Report of Unanticipated Difficult Intubation Due to Posterior Tracheal Angulation.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2026
Same author

The global hydrogen budget.

Nature·2025
Same author

Olaparib, durvalumab, and cyclophosphamide, and a prognostic blood signature in platinum-sensitive ovarian cancer: the randomized phase 2 SOLACE2 trial.

Nature communications·2025
Same author

Augmented Reality in Airway Management: A Scoping Review.

Anesthesia and analgesia·2025
Same journal

A risk-based classification of late-onset fetal growth disorders according to intrapartum fetal compromise.

Best practice & research. Clinical obstetrics & gynaecology·2026
Same journal

The Cardiac-Fetal-Placental Unit: links between umbilical venous flow and maternal hemodynamics in fetal growth restriction.

Best practice & research. Clinical obstetrics & gynaecology·2026
Same journal

Psychosocial interventions for women who are pregnant following a previous reproductive loss: A scoping review.

Best practice & research. Clinical obstetrics & gynaecology·2026
Same journal

Controversies in fetal therapy.

Best practice & research. Clinical obstetrics & gynaecology·2026
Same journal

Alloimmunisation in pregnancy: current management and future perspectives.

Best practice & research. Clinical obstetrics & gynaecology·2026
Same journal

Consensus in prenatal management of Hemolytic disease of the fetus and newborn.

Best practice & research. Clinical obstetrics & gynaecology·2026
See all related articles

Related Experiment Video

Updated: May 25, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Endometrial cancer.

Vivek Arora1, Michael A Quinn

  • 1Royal Women's Hospital, Parkville, Victoria, Australia. vbbarora@yahoo.com

Best Practice & Research. Clinical Obstetrics & Gynaecology
|January 27, 2012
PubMed
Summary
This summary is machine-generated.

Fertility-sparing management for endometrial carcinoma is an option for select patients. Careful patient selection and awareness of potential risks like disease progression are crucial for this approach.

More Related Videos

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum
05:42

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum

Published on: January 26, 2024

Related Experiment Videos

Last Updated: May 25, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis
10:58

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum
05:42

An Ex Vivo Model of Ovarian Cancer Peritoneal Metastasis Using Human Omentum

Published on: January 26, 2024

Area of Science:

  • Gynecologic Oncology
  • Reproductive Endocrinology
  • Oncology

Background:

  • Endometrial carcinoma is the most common gynecologic malignancy in Western countries.
  • Standard treatment involves hysterectomy and bilateral salpingo-oophorectomy, often with lymph node dissection.
  • Fertility preservation is a growing concern for younger patients diagnosed with endometrial cancer.

Purpose of the Study:

  • To explore conservative management options for endometrial carcinoma in women desiring fertility preservation.
  • To identify patient selection criteria for conservative treatment of endometrial cancer.
  • To highlight the risks associated with fertility-sparing approaches for endometrial carcinoma.

Main Methods:

  • Review of current literature on conservative management of endometrial carcinoma.
  • Identification of criteria for selecting patients for fertility-sparing treatment.
  • Analysis of potential risks and outcomes associated with hormonal therapy for endometrial cancer.

Main Results:

  • Conservative management may be suitable for well-differentiated endometrial cancer without myometrial invasion or adnexal disease.
  • Disease progression during or after treatment is the primary concern with conservative approaches.
  • Hormonal therapy, while not standard, is a key component of conservative management.

Conclusions:

  • Fertility-sparing management of endometrial carcinoma is a viable option for carefully selected patients.
  • Informed consent regarding potential risks, including disease progression, is essential.
  • Further research is needed to optimize conservative treatment strategies and outcomes for endometrial cancer.